222315-01-7 Usage
Uses
Used in Organic Synthesis:
5-BROMO-2-ISOBUTOXYBENZALDEHYDE is used as a building block for the synthesis of complex organic molecules, contributing to the development of new chemical entities with potential applications in various industries.
Used in Pharmaceutical Industry:
In the pharmaceutical sector, 5-BROMO-2-ISOBUTOXYBENZALDEHYDE is used as a starting material for the production of various drugs. Its unique structure allows for the creation of molecules with specific therapeutic properties, making it a valuable component in drug discovery and development.
Used in Agrochemical Industry:
5-BROMO-2-ISOBUTOXYBENZALDEHYDE also finds application in the agrochemical industry, where it is used in the synthesis of compounds with pesticidal or herbicidal properties. This contributes to the development of effective solutions for crop protection and management.
Safety Precautions:
It is important to handle 5-BROMO-2-ISOBUTOXYBENZALDEHYDE with care due to its potential harmful effects if swallowed, inhaled, or in contact with skin. It should be stored and handled in a well-ventilated area and with appropriate safety measures to ensure the safety of individuals working with 5-BROMO-2-ISOBUTOXYBENZALDEHYDE.
Check Digit Verification of cas no
The CAS Registry Mumber 222315-01-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,2,3,1 and 5 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 222315-01:
(8*2)+(7*2)+(6*2)+(5*3)+(4*1)+(3*5)+(2*0)+(1*1)=77
77 % 10 = 7
So 222315-01-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H13BrO2/c1-8(2)7-14-11-4-3-10(12)5-9(11)6-13/h3-6,8H,7H2,1-2H3
222315-01-7Relevant academic research and scientific papers
COMPOUNDS ACTING AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE
-
Page/Page column 70-71, (2013/07/05)
The present invention provides a compound, that is a 1-({halo-2-[(2-hydrocarbyl or substituted hydrocarbyl)oxy]phenyl}methyl)-(fused bicyclic nitrogen heteroaryl) carboxylic acid or an ester or sulfonamide thereof. The compound may be represented by the f
PROCESSES FOR THE PREPARATION OF FEBUXOSTAT AND SALTS THEREOF
-
Page/Page column 26, (2011/07/07)
There is provided a process for preparing febuxostat of formula (I) or a pharmaceutically acceptable salt thereof, the process comprising: condensing a compound of formula (A) with a compound of formula (B) to form an ester of febuxostat; hydrolyzing the ester of febuxostat to febuxostat, and optionally converting the febuxostat to a pharmaceutically acceptable salt thereof, wherein: R' is an activating group selected from boronic acid or lithium; R is selected from optionally substituted C1-4 alkyl or optionally substituted aryl; L is a leaving group selected from diazo, halo, -OSO2R", -OCOR" or -O-Si(R")3; and R" is selected from optionally substituted C1-4 alkyl or optionally substituted aryl.
PYRROLE COMPOUNDS
-
Page/Page column 27, (2010/02/12)
Compounds of formula (I) or a derivative thereof: wherein A, B, Z, R1, R2a, R2b, Rx, R8, and R9 are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such
